146 related articles for article (PubMed ID: 12504112)
1. The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.
Sangvanich P; Mackness B; Gaskell SJ; Durrington P; Mackness M
Biochem Biophys Res Commun; 2003 Jan; 300(2):501-6. PubMed ID: 12504112
[TBL] [Abstract][Full Text] [Related]
2. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
Mackness MI; Arrol S; Abbott C; Durrington PN
Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
[TBL] [Abstract][Full Text] [Related]
3. Lack of protection against oxidative modification of LDL by avian HDL.
Mackness B; Durrington PN; Mackness MI
Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
[TBL] [Abstract][Full Text] [Related]
4. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
Parthasarathy S; Barnett J; Fong LG
Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
[TBL] [Abstract][Full Text] [Related]
6. Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages.
Girona J; La Ville AE; Heras M; Olivé S; Masana L
Free Radic Biol Med; 1997; 23(4):658-67. PubMed ID: 9215811
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
Greilberger J; Jürgens G
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein.
Mackness MI; Arrol S; Durrington PN
FEBS Lett; 1991 Jul; 286(1-2):152-4. PubMed ID: 1650712
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-lipid association in oxidatively modified HDL and LDL.
Shoukry MI; Gong EL; Nichols AV
Biochim Biophys Acta; 1994 Jan; 1210(3):355-60. PubMed ID: 8305491
[TBL] [Abstract][Full Text] [Related]
10. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
11. High density lipoprotein subclasses inhibit low density lipoprotein oxidation.
Singh K; Chander R; Kapoor NK
Indian J Biochem Biophys; 1997 Jun; 34(3):313-8. PubMed ID: 9425752
[TBL] [Abstract][Full Text] [Related]
12. 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins.
Uchida K; Osawa T; Hiai H; Toyokuni S
Biochem Biophys Res Commun; 1995 Jul; 212(3):1068-73. PubMed ID: 7626094
[TBL] [Abstract][Full Text] [Related]
13. Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction.
Decossin C; Tailleux A; Fruchart JC; Fiévet C
Biochim Biophys Acta; 1995 Mar; 1255(1):31-8. PubMed ID: 7893735
[TBL] [Abstract][Full Text] [Related]
14. Plasmalogen oxidation in human serum lipoproteins.
Felde R; Spiteller G
Chem Phys Lipids; 1995 Jun; 76(2):259-67. PubMed ID: 7634364
[TBL] [Abstract][Full Text] [Related]
15. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.
Mackness MI; Abbott C; Arrol S; Durrington PN
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):829-34. PubMed ID: 8379937
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients.
Morena M; Cristol JP; Dantoine T; Carbonneau MA; Descomps B; Canaud B
Nephrol Dial Transplant; 2000 Mar; 15(3):389-95. PubMed ID: 10692526
[TBL] [Abstract][Full Text] [Related]
17. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification.
Nenseter MS; Gudmundsen O; Malterud KE; Berg T; Drevon CA
Biochim Biophys Acta; 1994 Jul; 1213(2):207-14. PubMed ID: 8025132
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE.
Annangudi SP; Deng Y; Gu X; Zhang W; Crabb JW; Salomon RG
Chem Res Toxicol; 2008 Jul; 21(7):1384-95. PubMed ID: 18570390
[TBL] [Abstract][Full Text] [Related]
20. HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: studies in transgenic mice.
Hayek T; Oiknine J; Dankner G; Brook JG; Aviram M
Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):721-5. PubMed ID: 8608194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
